Breast Cancer with Low Recurrence Score on Oncotype DX©: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation

被引：0

作者：

Yonaton Zarbiv

Yael Berner Wygoda

Albert Grinshpun

Tamar Hamburger

Tamar Sella

Shani Breuer

Ofra Maimon

Yakir Rottenberg

Tamar Peretz

Luna Kadouri

机构：

[1] Sharett Institute of Oncology,Faculty of Medicine

[2] Hadassah Medical Center,Department of Radiology

[3] The Hebrew University of Jerusalem,undefined

[4] Wohl Institute for Translational Medicine,undefined

[5] Hadassah Medical Center,undefined

[6] Hadassah Medical Center,undefined

来源：

Oncology and Therapy | 2022年 / 10卷

关键词：

Breast cancer; Recurrence; Recurrence score; BRCA1/2; Invasive lobular carcinoma; Prognostic genomic test; Predictive genomic test;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：441 / 450

页数：9

共 50 条

[31] Invasive Lobular Carcinoma and Oncotype Dx®: Impact of Pathology and Recurrence Score on Treatment Plan
Ross, D. S.
Galman, L. C.
Catalano, J.
Tan, L. K.
LABORATORY INVESTIGATION, 2012, 92 : 64A - 64A
[32] Can high Ki67 predict distant recurrence in early stage breast cancer with low oncotype Dx score?
Fallah, P.
Mulla, N.
Rose, A. A. N.
Panasci, L.
ANNALS OF ONCOLOGY, 2021, 32 : S425 - S426
[33] Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia
Lindsay J. Collin
Ming Yan
Renjian Jiang
Kevin C. Ward
Brittany Crawford
Mylin A. Torres
Keerthi Gogineni
Preeti D. Subhedar
Samantha Puvanesarajah
Mia M. Gaudet
Lauren E. McCullough
npj Breast Cancer, 5
[34] Clinical Impact of a Novel Model Predictive of Oncotype DX Recurrence Score in Breast Cancer
Yamamoto, Shinya
Chishima, Takashi
Shibata, Yukako
Harada, Fumi
Takeuchi, Hideki
Yamada, Akimitsu
Narui, Kazutaka
Misumi, Toshihiro
Ishikawa, Takashi
Endo, Itaru
IN VIVO, 2021, 35 (04): : 2439 - 2444
[35] Association between estrogen receptor status and Oncotype Dx breast recurrence score.
Khan, Noman Ahmed Jang
Abdallah, Mahmoud
Gress, Todd W.
Alsharedi, Mohamed Farouq
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[36] Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia
Collin, Lindsay J.
Yan, Ming
Jiang, Renjian
Ward, Kevin C.
Crawford, Brittany
Torres, Mylin A.
Gogineni, Keerthi
Subhedar, Preeti D.
Puvanesarajah, Samantha
Gaudet, Mia M.
McCullough, Lauren E.
NPJ BREAST CANCER, 2019, 5 (1)
[37] Proposed criteria for luminal A breast cancer accurately predict Oncotype dx™ recurrence score
Heinemann, F. S.
BREAST, 2015, 24 : S116 - S116
[38] Correlation between clinicopathological characteristics and oncotype Dx recurrence score (RS) in early breast cancer. Experience in a Mexican population
Amador-Garcia, Geovani
Alexandra Rodriguez-Melendez, Elina
Fabian Martinez-Herrera, Jose
Alejandro Andrade-Moreno, Raul
Reyes-Sanchez, Eduardo
Vazquez-Juarez, Daniela
Lopez-Zepeda, Lorena
Padilla-Rodriguez, Alvaro
Manuel Olivares-Beltran, Guillermo
Villalobos-Prieto, Alberto
Aguayo-Gonzalez, Alvaro
Perez-Zincer, Fernando
Patricio Camacho-Limas, Christian
Miguel Lazaro-Leon, Jose
Alberto Serrano-Olvera, Juan
Gerson-Cwilich, Raquel
CANCER RESEARCH, 2020, 80 (04)
[39] Oncotype-DX recurrence score distribution among breast cancer patients harboring a germline mutation in the BRCA1/2 genes.
Lewin, Ron
Rizel, Shulamith
Hendler, Daniel
Neiman, Victoria
Ben-Aharon, Irit
Liebermann, Nicky
Margel, David
Zoref, Dalia
Sulkes, Aaron
Yerushalmi, Rinat
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[40] Comparison of Oncotype DX Recurrence Score by Histologic Types of Breast Carcinoma
Bomeisl, Philip E.
Thompson, Cheryl L.
Harris, Lyndsay N.
Gilmore, Hannah L.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (12) : 1546 - 1549

← 1 2 3 4 5 →